Unlocking the potential of double negative memory B cells in cancer treatment
Unlocking the Potential of Dysfunctional B Cells in Cancer Therapy The recent discovery by scientists at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center has opened a groundbreaking avenue in cancer research. By identifying a novel subset of cancer-fighting immune cells—double negative memory B cells—outside their standard locale, researchers have paved … Read more